MSB mesoblast limited
Add to My Watchlist 2.97% ! $1.80

Aren't we lucky to have Ryoncil approved before all these FDA...

  1. ddwn
    13,184 Posts.
    lightbulb Created with Sketch. 3619
    clock Created with Sketch.
    11/06/25
    10:51
    Post #: 79388951
    Aren't we lucky to have Ryoncil approved before all these FDA changes? biggrin.png
    It would have been miserable for us MSB'ers right now - if Ryoncil wasn't approved as yet!
    MSB Price at posting: $1.88 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 16  Upvote
    lightbulb Created with Sketch. 2  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Anson Completes Maiden JORC Mineral Resources Estimate at Green River Lithium Project
right-arrow Created with Sketch.
NEWS Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)
right-arrow Created with Sketch.
WCE West Coast Silver Identifies Shallow High-Grade Mineralisation in Early Drilling
right-arrow Created with Sketch.
NEWS Galactica Drilling Program Complete as Blue Star Transitions to Commercial Production
right-arrow Created with Sketch.
NEWS Argenica Receives FDA Investigational New Drug Application Update
right-arrow Created with Sketch.
NEWS High-Grade Assays Confirm Multiple Parallel Zones at Golden Eye
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$1.80 		Change
-0.055(2.97%) 		Mkt cap ! $2.293B
Open High Low Value Volume
$1.84 $1.86 $1.77 $7.241M 4.018M

Buyers (Bids)

No. Vol. Price($)
3 25472 $1.80
 

Sellers (Offers)

Price($) Vol. No.
$1.81 1500 1
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.